Austedo (deutetrabenazine) and Ingrezza (valbenazine) are prescription drugs used to treat tardive dyskinesia and chorea associated with Huntington’s disease. Austedo and Ingrezza are not available as ...

Credit: Getty Images. Austedo XR is a vesicular monoamine transporter 2 inhibitor. Austedo ® XR (deutetrabenazine) extended-release tablets are now available for the treatment of adults with tardive ...

Austedo (deutetrabenazine) is a prescription drug that’s taken to treat tardive dyskinesia and Huntington’s chorea. It comes as an oral tablet (Austedo) and an extended-release oral tablet (Austedo XR ...

People with uncontrolled movement problems can have a harder time doing everyday tasks such as speaking, reading, writing, and cooking, which can cause a loss of independence. This may cause people to ...

Austedo and Austedo XR treat tardive dyskinesia and chorea related to Huntington’s disease in adults. The dosage varies depending on the condition. Austedo typically starts at 6 mg twice daily.

JERUSALEM & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Neuroscience, Inc., an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that new study data on AUSTEDO® ...

In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their lives impacted by tardive dyskinesia (TD) while taking AUSTEDO or AUSTEDO ...